Two Sigma Advisers
ABEO icon

Two Sigma Advisers’s Abeona Therapeutics ABEO Stock Holding History

Two Sigma Advisers’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-552
Closed -$3K – 2519
2022
Q2 		$3K Sell
552
-1,028
-65% -$5.2K ﹤0.01% 2614
2022
Q1 		$12K Buy
1,580
+324
+26% +$2.23K ﹤0.01% 2689
2021
Q4 		$11K Buy
+1,256
New +$23.1K ﹤0.01% 2569
2020
Q3 		– Sell
-1,816
Closed -$132K – 2375
2020
Q2 		$132K Buy
1,816
+1,032
+132% +$71.3K ﹤0.01% 2323
2020
Q1 		$41K Sell
784
-152
-16% -$10.2K ﹤0.01% 2386
2019
Q4 		$77K Sell
936
-368
-28% -$26K ﹤0.01% 2271
2019
Q3 		$74K Buy
+1,304
New +$97.6K ﹤0.01% 2131

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers's ABEO Position: Q3 2022 in Review

Two Sigma Advisers sold out of Abeona Therapeutics (ABEO) in Q3 2022, closing a stake of 552 shares — an estimated $3K sold.

Two Sigma Advisers first reported a position in ABEO in Q3 2019 and held it in 7 quarters. The position peaked at $132K in Q2 2020. 24 funds tracked by Wall St. Rank hold ABEO as of Q3 2022.

  • Two Sigma Advisers reported no remaining Abeona Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 552 Abeona Therapeutics shares in Q3 2022, an estimated $3K.
  • Two Sigma Advisers first reported a position in Abeona Therapeutics in Q3 2019 and held it in 7 quarters.
  • Two Sigma Advisers's Abeona Therapeutics position peaked at $132K in Q2 2020.
  • 24 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.